Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza for Cardiovascular Risk in HIV
NCT01001767Phase 2Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Apr 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in cardiovascular diseases (CVD), sponsored by University Hospitals Cleveland Medical Center. Started Apr 2009; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT01001767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001767.